Christopher R. Cline - Net Worth and Insider Trading
Christopher R. Cline Net Worth
The estimated net worth of Christopher R. Cline is at least $1 Million dollars as of 2024-11-29. Christopher R. Cline is the CHIEF FINANCIAL OFFICER of Travere Therapeutics Inc and owns about 74,595 shares of Travere Therapeutics Inc (TVTX) stock worth over $1 Million. Details can be seen in Christopher R. Cline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher R. Cline has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher R. Cline
Christopher R. Cline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher R. Cline owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .
Click here to see the complete history of Christopher R. Cline’s form 4 insider trades.
Insider Ownership Summary of Christopher R. Cline
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-09-09 | Chief Financial Officer |
Christopher R. Cline Latest Holdings Summary
Christopher R. Cline currently owns a total of 1 stock. Christopher R. Cline owns 74,595 shares of Travere Therapeutics Inc (TVTX) as of September 9, 2024, with a value of $1 Million.
Latest Holdings of Christopher R. Cline
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-09-09 | 74,595 | 18.70 | 1,394,927 |
Holding Weightings of Christopher R. Cline
Christopher R. Cline Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher R. Cline has made a total of 9 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 2,490 shares on September 9, 2024, which brought Christopher R. Cline around $28,685.
Insider Trading History of Christopher R. Cline
- 1
Christopher R. Cline Trading Performance
Christopher R. Cline Ownership Network
Christopher R. Cline Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Christopher R. Cline is the Chief Financial Officer of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include VP & Corp Controller and CAO Sandra Calvin , Chief Medical Officer Jula Inrig , and Senior Vice President & R&D William E. Rote .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Christopher R. Cline made 5 insider transaction in Travere Therapeutics Inc (TVTX) with a net sale of 4,368. Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 33,453 shares made by Eric M Dube , a net sale of 8,264 shares made by Elizabeth E Reed , and a net sale of 8,264 shares made by William E. Rote .
In summary, during the past 3 months, insiders sold 130,059 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 130,059 shares. During the past 18 months, 159,574 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,574 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Christopher R. Cline Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher R. Cline. You might contact Christopher R. Cline via mailing address: C/o Travere Therapeutics, Inc., 3611 Valley Centre Drive, Ste 300, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
